Prognostic significance of clusterin expression in advanced-stage cervical cancer treated with curative intended radiotherapy. 2012

Hidemichi Watari, and Rumiko Kinoshita, and Yimin Han, and Lei Wang, and Masayoshi Hosaka, and Hiroshi Taguchi, and Kazuhiko Tsuchiya, and Shinya Tanaka, and Hiroki Shirato, and Noriaki Sakuragi
Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. watarih@med.hokudai.ac.jp

OBJECTIVE Overexpression of clusterin (CLU), an antiapoptotic molecule, has been reported to induce resistance to radiotherapy (RT) in a variety of cancer cell types. The aim of this study was to evaluate the significance of CLU expression to predict survival of patients with advanced-stage cervical cancer who received curative intended RT. METHODS Biopsy tissue specimens of advanced-stage cervical cancer before curative intended RT were obtained from 34 patients who were treated at Hokkaido University Hospital between 1998 and 2008 and whose complete medical records were available. The expression of CLU protein was analyzed by immunohistochemistry. Findings were evaluated in relation to several clinicopathological factors. Survival analyses were performed using the Kaplan-Meier curves and the log-rank test. Independent prognostic factors were determined by multivariate Cox regression analysis. RESULTS Clusterin protein was mainly present in the cytoplasm of cervical cancer cells. The expression of CLU protein in cervical cancer tissues before curative intended RT was not significantly related to any clinicopathological factors analyzed, including age, clinical stage, histologic type, and response to RT. Univariate analysis on prognostic factors showed that histologic type (P = 0.001), and CLU expression (P = 0.02) were related to survival. Multivariate analysis revealed that both histologic type (P = 0.002), and CLU expression (P = 0.02) were independent prognostic factors for overall survival. CONCLUSIONS We conclude that CLU could be a new molecular marker to predict overall survival of patients with advanced-stage cervical cancer treated with curative intended RT.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Hidemichi Watari, and Rumiko Kinoshita, and Yimin Han, and Lei Wang, and Masayoshi Hosaka, and Hiroshi Taguchi, and Kazuhiko Tsuchiya, and Shinya Tanaka, and Hiroki Shirato, and Noriaki Sakuragi
September 2012, International journal of radiation oncology, biology, physics,
Hidemichi Watari, and Rumiko Kinoshita, and Yimin Han, and Lei Wang, and Masayoshi Hosaka, and Hiroshi Taguchi, and Kazuhiko Tsuchiya, and Shinya Tanaka, and Hiroki Shirato, and Noriaki Sakuragi
January 2015, Akusherstvo i ginekologiia,
Hidemichi Watari, and Rumiko Kinoshita, and Yimin Han, and Lei Wang, and Masayoshi Hosaka, and Hiroshi Taguchi, and Kazuhiko Tsuchiya, and Shinya Tanaka, and Hiroki Shirato, and Noriaki Sakuragi
December 1980, Cancer,
Hidemichi Watari, and Rumiko Kinoshita, and Yimin Han, and Lei Wang, and Masayoshi Hosaka, and Hiroshi Taguchi, and Kazuhiko Tsuchiya, and Shinya Tanaka, and Hiroki Shirato, and Noriaki Sakuragi
November 2015, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
Hidemichi Watari, and Rumiko Kinoshita, and Yimin Han, and Lei Wang, and Masayoshi Hosaka, and Hiroshi Taguchi, and Kazuhiko Tsuchiya, and Shinya Tanaka, and Hiroki Shirato, and Noriaki Sakuragi
January 1992, Urology,
Hidemichi Watari, and Rumiko Kinoshita, and Yimin Han, and Lei Wang, and Masayoshi Hosaka, and Hiroshi Taguchi, and Kazuhiko Tsuchiya, and Shinya Tanaka, and Hiroki Shirato, and Noriaki Sakuragi
January 2019, Obstetrics & gynecology science,
Hidemichi Watari, and Rumiko Kinoshita, and Yimin Han, and Lei Wang, and Masayoshi Hosaka, and Hiroshi Taguchi, and Kazuhiko Tsuchiya, and Shinya Tanaka, and Hiroki Shirato, and Noriaki Sakuragi
January 2005, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
Hidemichi Watari, and Rumiko Kinoshita, and Yimin Han, and Lei Wang, and Masayoshi Hosaka, and Hiroshi Taguchi, and Kazuhiko Tsuchiya, and Shinya Tanaka, and Hiroki Shirato, and Noriaki Sakuragi
May 2021, Oncology letters,
Hidemichi Watari, and Rumiko Kinoshita, and Yimin Han, and Lei Wang, and Masayoshi Hosaka, and Hiroshi Taguchi, and Kazuhiko Tsuchiya, and Shinya Tanaka, and Hiroki Shirato, and Noriaki Sakuragi
May 2002, International journal of cancer,
Hidemichi Watari, and Rumiko Kinoshita, and Yimin Han, and Lei Wang, and Masayoshi Hosaka, and Hiroshi Taguchi, and Kazuhiko Tsuchiya, and Shinya Tanaka, and Hiroki Shirato, and Noriaki Sakuragi
July 2014, British journal of cancer,
Copied contents to your clipboard!